DarioHealth Corp. (DRIO) stock
DRIONasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 8/3099% below fair value
$1.32−0.12 (-8.33%)
Close on Nov 20, 2026Market cap $12.94MP/E 0.3Yield –
DarioHealth net income
Net income is the profit left for shareholders after every expense, interest and tax.
DarioHealth's net income for the twelve months ending Jun 30, 2026 was -$35.67M. For fiscal 2025 it was -$41.71M. The highest annual figure on record is -$5.69M in fiscal 2012.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$41.71M | – |
| FY2024 | Dec 31, 2024 | -$42.75M | – |
| FY2023 | Dec 31, 2023 | -$59.43M | – |
| FY2022 | Dec 31, 2022 | -$62.19M | – |
| FY2021 | Dec 31, 2021 | -$76.76M | – |
| FY2020 | Dec 31, 2020 | -$29.45M | – |
| FY2019 | Dec 31, 2019 | -$17.74M | – |
| FY2018 | Dec 31, 2018 | -$17.80M | – |
| FY2017 | Dec 31, 2017 | -$15.74M | – |
| FY2016 | Dec 31, 2016 | -$10.89M | – |
| FY2015 | Dec 31, 2015 | -$7.14M | – |
| FY2014 | Dec 31, 2014 | -$12.88M | – |
| FY2013 | Dec 31, 2013 | -$13.93M | – |
| FY2012 | Dec 31, 2012 | -$5.69M | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$7.92M | – |
| Q1 FY2026 | Mar 31, 2026 | -$8.25M | – |
| Q4 FY2025 | Dec 31, 2025 | -$9.03M | – |
| Q3 FY2025 | Sep 30, 2025 | -$10.47M | – |
| Q2 FY2025 | Jun 30, 2025 | -$12.99M | – |
| Q1 FY2025 | Mar 31, 2025 | -$9.23M | – |
| Q4 FY2024 | Dec 31, 2024 | -$9.63M | – |
| Q3 FY2024 | Sep 30, 2024 | -$12.33M | – |
| Q2 FY2024 | Jun 30, 2024 | -$13.61M | – |
| Q1 FY2024 | Mar 31, 2024 | -$7.18M | – |
| Q4 FY2023 | Dec 31, 2023 | -$14.29M | – |
| Q3 FY2023 | Sep 30, 2023 | -$15.73M | – |
| Q2 FY2023 | Jun 30, 2023 | -$16.59M | – |
| Q1 FY2023 | Mar 31, 2023 | -$12.83M | – |
| Q4 FY2022 | Dec 31, 2022 | -$12.62M | – |
| Q3 FY2022 | Sep 30, 2022 | -$15.63M | – |
| Q2 FY2022 | Jun 30, 2022 | -$18.03M | – |
| Q1 FY2022 | Mar 31, 2022 | -$15.92M | – |
| Q4 FY2021 | Dec 31, 2021 | -$21.59M | – |
| Q3 FY2021 | Sep 30, 2021 | -$22.44M | – |
| Q2 FY2021 | Jun 30, 2021 | -$17.77M | – |
| Q1 FY2021 | Mar 31, 2021 | -$14.97M | – |
| Q4 FY2020 | Dec 31, 2020 | -$9.00M | – |
| Q3 FY2020 | Sep 30, 2020 | -$6.55M | – |
| Q2 FY2020 | Jun 30, 2020 | -$4.01M | – |
| Q1 FY2020 | Mar 31, 2020 | -$9.89M | – |
| Q4 FY2019 | Dec 31, 2019 | -$4.17M | – |
| Q3 FY2019 | Sep 30, 2019 | -$2.81M | – |
| Q2 FY2019 | Jun 30, 2019 | -$5.38M | – |
| Q1 FY2019 | Mar 31, 2019 | -$5.38M | – |
| Q4 FY2018 | Dec 31, 2018 | -$4.98M | – |
| Q3 FY2018 | Sep 30, 2018 | -$4.06M | – |
| Q2 FY2018 | Jun 30, 2018 | -$5.84M | – |
| Q1 FY2018 | Mar 31, 2018 | -$2.92M | – |
| Q4 FY2017 | Dec 31, 2017 | -$3.27M | – |
| Q3 FY2017 | Sep 30, 2017 | -$2.97M | – |
| Q2 FY2017 | Jun 30, 2017 | -$4.09M | – |
| Q1 FY2017 | Mar 31, 2017 | -$5.41M | – |
| Q4 FY2016 | Dec 31, 2016 | -$3.86M | – |
| Q3 FY2016 | Sep 30, 2016 | -$611.00K | – |
See a number that looks wrong?